Physician profile
Michael Lam
NPI 1346651387
$11,594.58
in general payments reported to CMS, 2019-2025
42 companies · $1,981 in 2025
The $1,981 reported for 2025 was more than what 83% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.82 · 2020: $215 · 2021: $2,726 · 2022: $2,960 · 2023: $1,534 · 2024: $2,095 · 2025: $1,981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,184 · Travel and Lodging: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,183.84 |
| Travel and Lodging | $425.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $4,800.00 | 2021-2022 | |
| Mimedx Group, INC. | $1,320.51 | 2024-2025 | |
| Kerecis Limited | $736.24 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Musculoskeletal Transplant Foundation INC. | $716.93 | 2021-2025 | |
| Treace Medical Concepts, INC. | $620.82 | 2022-2025 | |
| Stryker Corporation | $499.85 | 2020-2025 | Na, Flexband, Variax |
| Biowound Solutions, INC. | $333.88 | 2025 | Bio-Connekt |
| Integra Lifesciences Corporation | $255.56 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paratek Pharmaceuticals, INC. | $253.96 | 2022-2025 | Nuzyra |
| Smith+Nephew, INC. | $253.70 | 2021-2025 | Stravix, Renasys Go V2 Home, Hat-Trick |
| Alafair Biosciences, INC. | $173.93 | 2025 | Versawrap |
| Amgen INC. | $162.17 | 2024-2025 | Krystexxa |
| Orthofix Medical, INC. | $156.45 | 2019-2023 | Physio-Stim |
| Nevro Corp. | $148.53 | 2022-2024 | Senza |
| Vertex Pharmaceuticals Incorporated | $119.25 | 2024-2025 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Koya Medical, INC. | $119.04 | 2022 | |
| Tactile Systems Technology INC | $97.28 | 2019-2023 | Flexitouch Plus, Entre Plus |
| Reprise Biomedical, INC. | $92.43 | 2023-2025 | Miro3d |
| Medshape, INC. | $65.40 | 2024 | Dynanail |
| Grt US Holding, INC. | $52.59 | 2021-2022 | |
| Davol INC. | $52.02 | 2025 | Surgiphor |
| Misonix INC | $51.05 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $51.01 | 2023 | Jublia |
| Organogenesis INC. | $45.19 | 2022 | |
| Acera Surgical, INC. | $42.41 | 2025 | Restrata Wound Matrix |
| Bioventus LLC | $37.82 | 2021 | |
| Solventum Corporation | $35.08 | 2024-2025 | Activ.A.C. |
| Urgo Medical North America, LLC | $31.40 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Djo, LLC | $27.74 | 2019-2021 | |
| Innovation Technologies INC | $25.08 | 2023 | Irrisept |
| Depuy Synthes Sales INC. | $22.95 | 2021 | |
| Polynovo North America LLC | $21.87 | 2024 | Novosorb Btm |
| Kci USA, INC. | $21.36 | 2019 | |
| Dynasplint Systems INC. | $21.00 | 2019 | |
| Medtronic, INC. | $20.38 | 2025 | Inceptiv |
| Melinta Therapeutics, LLC | $19.35 | 2021 | |
| Lifenet Health | $18.50 | 2025 | Theragenesis Wound Matrix |
| Acell, INC. | $17.59 | 2020 | |
| Convatec INC. | $17.21 | 2023 | |
| Sanara Medtech INC. | $15.44 | 2022 | |
| Medline Industries Lp | $11.33 | 2021 | |
| Heron Therapeutics, INC. | $10.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.